Investigation of the Therapeutic Potential of Organic Nitrates in Mortality Reduction Following Acute Myocardial Infarction in Hyperlipidemia Patients: A Population-Based Cohort Study

Investigation of the Therapeutic Potential of Organic Nitrates in Mortality Reduction Following Acute Myocardial Infarction in Hyperlipidemia Patients: A Population-Based Cohort Study

Background: Dyslipidemia is a known risk factor for cardiac dysfunction, and lipid-lowering therapy with statins reduces symptoms and reduces hospitalization related to left ventricular heart failure. Acute myocardial infarction (AMI) is a cause of morbidity and mortality worldwide. In this study, w...

Full description

Bibliographic Details
Main Authors:	An-Sheng Lee, Chung-Lieh Hung, Thung-Shen Lai, Ching-Hu Chung
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Journal of Personalized Medicine
Subjects:	hyperlipidemia acute myocardial infarction organic nitrates beta-blockers all-cause mortality
Online Access:	https://www.mdpi.com/2075-4426/14/1/124

Similar Items

Beta adrenergic blokade in myocardial infarction
by: Yusuf, S
Published: (1980)

THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION
by: A. N. Zakirova, et al.
Published: (2017-12-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

Association between living alone and all-cause mortality of young and middle-aged patients with acute myocardial infarction: analysis of the China Acute Myocardial Infarction (CAMI) registry
by: Yu Jiang, et al.
Published: (2024-01-01)

Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?
by: Roberto F.E. Pedretti
Published: (2018-06-01)

The bisoprolol efficiency predictors in patients with stable angina after myocardial infarction
by: O. V. Zamakhina, et al.
Published: (2019-04-01)

Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
by: Liyew Desta, et al.
Published: (2021-02-01)

Treatment and secondary prevention of myocardial infarction
by: E. V. Kuleshova, et al.
Published: (2013-12-01)

High serum uric acid trajectories are associated with risk of myocardial infarction and all-cause mortality in general Chinese population
by: Xue Tian, et al.
Published: (2022-06-01)

β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study
by: Tora Hagsund, et al.
Published: (2020-04-01)

Retinal Artery Occlusion and Its Impact on the Incidence of Stroke, Myocardial Infarction, and All-Cause Mortality during 12-Year Follow-Up
by: Joanna Roskal-Wałek, et al.
Published: (2022-07-01)

The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in critically ill patients with acute myocardial infarction
by: Ya Lin, et al.
Published: (2022-03-01)

Statin drugs mitigate cellular inflammatory response after ST elevation myocardial infarction, but do not affect in-hospital mortality
by: Leili Pourafkari, et al.
Published: (2016-03-01)

Long-Term Effect of Non-Selective Beta-Blockers in Patients With Rheumatoid Arthritis After Myocardial Infarction—A Nationwide Cohort Study
by: Sheng-Fu Liu, et al.
Published: (2021-09-01)

Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry
by: Jaehoon Chung, et al.
Published: (2021-03-01)

Discharge Heart Rate After Hospitalization for Myocardial Infarction and Long‐Term Mortality in 2 US Registries
by: Venkatesh Alapati, et al.
Published: (2019-02-01)

Association of serum total 25-hydroxy-vitamin D concentration and risk of all-cause, cardiovascular and malignancies-specific mortality in patients with hyperlipidemia in the United States
by: Xueqin Chen, et al.
Published: (2022-10-01)

Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study
by: Jaehoon Chung, et al.
Published: (2017-10-01)

Base excess is associated with the risk of all-cause mortality in critically ill patients with acute myocardial infarction
by: Chaodi Luo, et al.
Published: (2022-08-01)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
by: Tianyu Xu, et al.
Published: (2019-06-01)

Effect of prior beta-blocker use on in-hospital atrial fibrillation development in patients with ST-elevation myocardial infarction
by: Fatih Kahraman, et al.
Published: (2022-04-01)

Risk Factors for Senile Corneal Arcus in Patients with Acute Myocardial Infarction
by: Mirnaghi Moosavi, et al.
Published: (2010-01-01)

The prognostic nutritional index predicts all-cause mortality in critically ill patients with acute myocardial infarction
by: Yuekang Huang, et al.
Published: (2023-07-01)

The Hypertension Paradox: Survival Benefit After ST-Elevation Myocardial Infarction in Patients With History of Hypertension. A Prospective Cohort- and Risk-Analysis
by: Fabian Hoffmann, et al.
Published: (2022-02-01)

The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
by: Oriol Iborra-Egea, et al.
Published: (2022-07-01)

Cumulative Serum Uric Acid and Its Time Course Are Associated With Risk of Myocardial Infarction and All‐Cause Mortality
by: Xue Tian, et al.
Published: (2021-07-01)

Rosuvastatin and ellagic acid protect against isoproterenol-induced myocardial infarction in hyperlipidemic rats
by: Mai A. Elhemely, et al.
Published: (2014-12-01)

EFFICACY AND SAFETY OF BETA-ADRENOBLOCKER TREATMENT DURING POSTOPERATIONAL PERIOD AFTER EXTRACARDIAL SURGERY - A PARADIGM SHIFT?
by: Yu. V. Shchukin, et al.
Published: (2014-09-01)

β‐Blocker Therapy After Myocardial Infarction: A Little Goes a Long Way
by: J. Dawn Abbott, et al.
Published: (2023-08-01)

Comparative Effectiveness of Long‐Term Maintenance Beta‐Blocker Therapy After Acute Myocardial Infarction in Stable, Optimally Treated Patients Undergoing Percutaneous Coronary Intervention
by: Myunhee Lee, et al.
Published: (2023-08-01)

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction
by: William H Frishman, et al.
Published: (2008-12-01)

Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era
by: Mengjin Hu, et al.
Published: (2022-08-01)

Association between serum anion gap and all-cause mortality in patients with acute myocardial infarction: A retrospective study based on MIMIC-IV database
by: Jianhong Lu, et al.
Published: (2023-07-01)

Association of stress hyperglycemia with clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a cohort study
by: Qu-Cheng Wei, et al.
Published: (2023-04-01)

Beta-Blocker and Renin–Angiotensin System Inhibitor Combination Therapy in Patients with Acute Myocardial Infarction and Prediabetes or Diabetes Who Underwent Successful Implantation of Newer-Generation Drug-Eluting Stents: A Retrospective Observational Registry Study
by: Yong Hoon Kim, et al.
Published: (2020-10-01)

Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial
by: Anna Meta Dyrvig Kristensen, et al.
Published: (2020-05-01)

Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study
by: Christel Bruggmann, et al.
Published: (2020-08-01)

The Association between Acute Myocardial Infarction-Related Outcomes and the Ramadan Period: A Retrospective Population-Based Study
by: Batya Betesh-Abay, et al.
Published: (2022-08-01)

Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry
by: Tommaso Bucci, et al.
Published: (2024-04-01)

THE USE OF INTRAVENOUS FORMS OF BETA-BLOCKERS IN ACUTE CORONARY SYNDROME
by: I. D. Astrakhantseva, et al.
Published: (2017-06-01)